Baird raised the price target for the Alkermes plc (NASDAQ:ALKS) stock to “an Outperform”. The rating was released on March 19, 2024, according to finviz. The resear ...
In a report released on June 6, Joel Beatty from Robert W. Baird maintained a Buy rating on Immutep (IMMP – Research Report), with a ...
The company’s shares closed last Friday at $33.31. Amsellem covers the Healthcare sector, focusing on stocks such as Alkermes, Ironwood Pharma, and Supernus Pharmaceuticals. According to TipRanks, ...
Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time stamp on this data. Updated AI-Generated Signals for Alkermes Plc (ALKS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback